amiodarone has been researched along with Arrhythmia, Sinoatrial in 21 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Excerpt | Relevance | Reference |
---|---|---|
"The study analyzed the role of different variables that determine long-term sinus rhythm maintenance in patients with persistent atrial fibrillation who are treated with amiodarone." | 7.72 | Pharmacologic reversion of persistent atrial fibrillation with amiodarone predicts long-term sinus rhythm maintenance. ( Blanco, MV; Bonato, R; Chiale, PA; Elizari, MV; Galperín, J; Lago, M; Ledesma, R; Molina, RT; Scapín, AO, 2003) |
" Four patients (11%) in group A but none in group B experienced significant adverse effects that necessitated withdrawal of amiodarone." | 6.72 | Long-term efficacy and safety of very-low-dose amiodarone treatment for the maintenance of sinus rhythm in patients with chronic atrial fibrillation after successful direct-current cardioversion. ( Chang, MH; Chang, TC; Chen, CY; Chou, P; Fu, CY; Jong, GP; Ma, TC; Tien, LY, 2006) |
"The study analyzed the role of different variables that determine long-term sinus rhythm maintenance in patients with persistent atrial fibrillation who are treated with amiodarone." | 3.72 | Pharmacologic reversion of persistent atrial fibrillation with amiodarone predicts long-term sinus rhythm maintenance. ( Blanco, MV; Bonato, R; Chiale, PA; Elizari, MV; Galperín, J; Lago, M; Ledesma, R; Molina, RT; Scapín, AO, 2003) |
" Four patients (11%) in group A but none in group B experienced significant adverse effects that necessitated withdrawal of amiodarone." | 2.72 | Long-term efficacy and safety of very-low-dose amiodarone treatment for the maintenance of sinus rhythm in patients with chronic atrial fibrillation after successful direct-current cardioversion. ( Chang, MH; Chang, TC; Chen, CY; Chou, P; Fu, CY; Jong, GP; Ma, TC; Tien, LY, 2006) |
" After restoration of sinus rhythm, several therapeutic protocols were used, often in the same patient: abstention, leading to 5 recurrences in 6 cases; treatment with betablockers in 12 patients with well tolerated or exercise-induced atrial tachycardia with 11 successes; amiodarone, with 4 relapses out of 5 when the dosage was less than 200 mg/m2/day and 13 successes out of 18 when the dosage was 200-250 mg/m2/day." | 1.29 | [Treatment and prognosis of tachyarrhythmia after atrial surgical repair of transposition of great vessels]. ( Aggoun, Y; Bonnet, D; Iserin, L; Kachaner, J; Sidi, D; Villain, E, 1996) |
" Furthermore, amiodarone may interact with beta-blocking agents and some of the calcium antagonists to produce symptomatic sinus bradycardia and sinus arrest, especially in a latent or overt sick sinus syndrome." | 1.27 | Drug interactions with amiodarone. ( Marcus, FI, 1983) |
"Fetal cardiac arrhythmias are usually first suspected on the basis of auscultatory findings during routine examination in pregnancy." | 1.27 | Treatment of fetal cardiac arrhythmias. ( Stewart, PA; Wladimiroff, JW, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (42.86) | 18.7374 |
1990's | 3 (14.29) | 18.2507 |
2000's | 8 (38.10) | 29.6817 |
2010's | 1 (4.76) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Van Wagoner, DR | 1 |
Kosior, D | 1 |
Szulc, M | 1 |
Zawadzka, M | 1 |
Pierścińska, M | 1 |
Stawicki, S | 1 |
Rabczenko, D | 1 |
Torbicki, A | 1 |
Opolski, G | 1 |
Galperín, J | 1 |
Elizari, MV | 1 |
Chiale, PA | 1 |
Molina, RT | 1 |
Ledesma, R | 1 |
Scapín, AO | 1 |
Blanco, MV | 1 |
Bonato, R | 1 |
Lago, M | 1 |
Lee, JK | 1 |
Klein, GJ | 1 |
Krahn, AD | 1 |
Yee, R | 1 |
Zarnke, K | 1 |
Simpson, C | 1 |
Skanes, A | 1 |
Gulizia, M | 2 |
Mangiameli, S | 2 |
Chiarandà, G | 2 |
Spadola, V | 1 |
Di Giovanni, N | 2 |
Colletti, A | 2 |
Bulla, V | 1 |
Circo, A | 1 |
Pensabene, O | 2 |
Vasquez, L | 2 |
Vaccaro, I | 1 |
Grammatico, A | 2 |
Klein, HH | 1 |
Jong, GP | 1 |
Chang, MH | 1 |
Chang, TC | 1 |
Chou, P | 1 |
Fu, CY | 1 |
Tien, LY | 1 |
Chen, CY | 1 |
Ma, TC | 1 |
Orazi, S | 1 |
Piccione, G | 1 |
Lisi, F | 1 |
Boriani, G | 1 |
Marcus, FI | 1 |
Pagnoni, F | 1 |
Arlotti, M | 1 |
Lotto, A | 1 |
Brodine, WN | 1 |
DeSantis, J | 1 |
Villain, E | 1 |
Bonnet, D | 1 |
Iserin, L | 1 |
Aggoun, Y | 1 |
Sidi, D | 1 |
Kachaner, J | 1 |
Donaldson, RM | 1 |
Heinz, G | 1 |
Ohner, T | 1 |
Laufer, G | 1 |
Gössinger, H | 1 |
Gasic, S | 1 |
Laczkovics, A | 1 |
Anastasio, R | 1 |
Facchin, L | 1 |
Gualandi, G | 1 |
Zannini, L | 1 |
Caturelli, G | 1 |
Nademanee, K | 1 |
Feld, G | 1 |
Hendrickson, J | 1 |
Intarachot, V | 1 |
Yale, C | 1 |
Heng, MK | 1 |
Singh, BN | 1 |
Wladimiroff, JW | 1 |
Stewart, PA | 1 |
Navalgund, AA | 1 |
Alifimoff, JK | 1 |
Jakymec, AJ | 1 |
Bleyaert, AL | 1 |
1 review available for amiodarone and Arrhythmia, Sinoatrial
Article | Year |
---|---|
[Dronedarone--a new therapeutic option for controlling atrial rhythm and ventricular frequency].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; Atrial Function | 2006 |
6 trials available for amiodarone and Arrhythmia, Sinoatrial
Article | Year |
---|---|
[Role amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; Electric Countersh | 2002 |
Rate-control versus conversion strategy in postoperative atrial fibrillation: trial design and pilot study results.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fib | 2003 |
Design and rationale of a randomized study to compare amiodarone and Class IC anti-arrhythmic drugs in terms of atrial fibrillation treatment efficacy in patients paced for sinus node disease: the PITAGORA trial.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; Cardiac Pacing, Artifici | 2006 |
Long-term efficacy and safety of very-low-dose amiodarone treatment for the maintenance of sinus rhythm in patients with chronic atrial fibrillation after successful direct-current cardioversion.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; Chronic Disease; C | 2006 |
A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; | 2008 |
Mexiletine: double-blind comparison with procainamide in PVC suppression and open-label sequential comparison with amiodarone in life-threatening ventricular arrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmia, Sinus; Benzofurans; Clinical Trials as Topic; Digestive System; | 1985 |
14 other studies available for amiodarone and Arrhythmia, Sinoatrial
Article | Year |
---|---|
Multi-channel blockers for treatment of atrial fibrillation: an effective strategy?
Topics: Amiodarone; Animals; Anisoles; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; Femal | 2013 |
Pharmacologic reversion of persistent atrial fibrillation with amiodarone predicts long-term sinus rhythm maintenance.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; Electric Co | 2003 |
Atrial fibrillation: rate control often better than rhythm control.
Topics: Adult; Aged; Amiodarone; Anticoagulants; Arrhythmia, Sinus; Atrial Fibrillation; Canada; Disopyramid | 2004 |
Drug interactions with amiodarone.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Benzofurans; Blo | 1983 |
[Pharmacological treatment of supraventricular hyperkinetic arrhythmia in sinus node disease: an alternative to electric treatment].
Topics: Adult; Aged; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Bunaftine; Disopyramid | 1983 |
Intravenous amiodarone in atrial fibrillation complicating myocardial infarction.
Topics: Amiodarone; Arrhythmia, Sinus; Atrial Fibrillation; Benzofurans; Humans; Male | 1982 |
Sinus arrest during treatment with amiodarone.
Topics: Amiodarone; Arrhythmia, Sinus; Benzofurans; Female; Humans; Middle Aged | 1982 |
[Treatment and prognosis of tachyarrhythmia after atrial surgical repair of transposition of great vessels].
Topics: Adolescent; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Card | 1996 |
[Modern therapy of tachycardiac heart arrhythmias].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; Atrial Flutter; Humans; | 1995 |
The treatment of supraventricular arrhythmias.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Arrhyt | 1979 |
Demographic and perioperative factors associated with initial and prolonged sinus node dysfunction after orthotopic heart transplantation. The impact of ischemic time.
Topics: Amiodarone; Arrhythmia, Sinus; Heart Rate; Heart Transplantation; Humans; Ischemia; Middle Aged; Mul | 1991 |
[Usefulness of pretreatment of patients with atrial fibrillation who are candidates for electric cardioversion].
Topics: Adult; Aged; Amiodarone; Arrhythmia, Sinus; Atrial Fibrillation; Electric Countershock; Female; Huma | 1988 |
Treatment of fetal cardiac arrhythmias.
Topics: Amiodarone; Arrhythmia, Sinus; Arrhythmias, Cardiac; Chromosome Aberrations; Chromosome Disorders; D | 1985 |
Amiodarone-induced sinus arrest successfully treated with ephedrine and isoproterenol.
Topics: Aged; Amiodarone; Arrhythmia, Sinus; Benzofurans; Cardiac Pacing, Artificial; Digoxin; Drug Interact | 1986 |